NL1032286A1 - Benzoaat zout van 4- (5-methyl-oxazoloó4,5-b!pyridin-2-yl)-1,4-diaza-bicycloó3,2,2!nonaan. - Google Patents

Benzoaat zout van 4- (5-methyl-oxazoloó4,5-b!pyridin-2-yl)-1,4-diaza-bicycloó3,2,2!nonaan.

Info

Publication number
NL1032286A1
NL1032286A1 NL1032286A NL1032286A NL1032286A1 NL 1032286 A1 NL1032286 A1 NL 1032286A1 NL 1032286 A NL1032286 A NL 1032286A NL 1032286 A NL1032286 A NL 1032286A NL 1032286 A1 NL1032286 A1 NL 1032286A1
Authority
NL
Netherlands
Prior art keywords
oxazolo
diaza
nonane
bicyclo
pyridin
Prior art date
Application number
NL1032286A
Other languages
English (en)
Other versions
NL1032286C2 (nl
Inventor
Kenneth George Kraus
Bruce Nelsen Rogers
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NL1032286A1 publication Critical patent/NL1032286A1/nl
Application granted granted Critical
Publication of NL1032286C2 publication Critical patent/NL1032286C2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL1032286A 2005-08-08 2006-08-08 Benzoaat zout van 4- (5-methyl-oxazoloó4,5-b!pyridin-2-yl)-1,4-diaza-bicycloó3,2,2!nonaan. NL1032286C2 (nl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70660105P 2005-08-08 2005-08-08
US70660105 2005-08-08

Publications (2)

Publication Number Publication Date
NL1032286A1 true NL1032286A1 (nl) 2007-02-09
NL1032286C2 NL1032286C2 (nl) 2007-08-07

Family

ID=37398316

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1032286A NL1032286C2 (nl) 2005-08-08 2006-08-08 Benzoaat zout van 4- (5-methyl-oxazoloó4,5-b!pyridin-2-yl)-1,4-diaza-bicycloó3,2,2!nonaan.

Country Status (6)

Country Link
AR (1) AR055111A1 (nl)
DO (1) DOP2006000185A (nl)
NL (1) NL1032286C2 (nl)
TW (1) TW200738734A (nl)
UY (1) UY29731A1 (nl)
WO (1) WO2007017750A1 (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009113950A1 (en) * 2008-03-10 2009-09-17 Astrazeneca Ab Therapeutic combinations of (a) an antipsychotic and (b) an alpha-4/beta-2 (a4b2)-neuronal nicotinic receptor agonist
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
EP3558276A1 (en) 2016-12-20 2019-10-30 LTS Lohmann Therapie-Systeme AG Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene
CN115813888A (zh) 2016-12-20 2023-03-21 罗曼治疗系统股份公司 包含阿塞那平的透皮治疗系统
CN107188900B (zh) * 2017-05-27 2019-09-06 北京师范大学 α7烟碱型乙酰胆碱受体的配体化合物及其应用
JP2020525545A (ja) 2017-06-26 2020-08-27 エルテーエス ローマン テラピー−ジステーメ アーゲー アセナピンおよびシリコーンアクリルハイブリッドポリマーを含有する経皮治療システム
MX2020014286A (es) 2018-06-20 2021-03-25 Lts Lohmann Therapie Systeme Ag Sistema terapeutico transdermico que contiene asenapina.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086871A1 (en) * 2000-12-29 2002-07-04 O'neill Brian Thomas Pharmaceutical composition for the treatment of CNS and other disorders
EP1699488A2 (en) * 2003-12-23 2006-09-13 Pfizer Products Incorporated Therapeutic combination for cognition enhancement and psychotic disorders

Also Published As

Publication number Publication date
DOP2006000185A (es) 2007-03-31
NL1032286C2 (nl) 2007-08-07
UY29731A1 (es) 2007-03-30
TW200738734A (en) 2007-10-16
WO2007017750A1 (en) 2007-02-15
AR055111A1 (es) 2007-08-08

Similar Documents

Publication Publication Date Title
NL1030863A1 (nl) Heteroaromatische chinolineverbindingen.
NL1031976A1 (nl) N-(pyridine-2-yl)sulfonamidederivativen.
DK2137184T3 (da) Imidazo[1,2-a]pyridinforbindelser som receptor-tyrosinkinaseinhibitorer
NL2000373A1 (nl) Antibacteriele middelen.
NL2000284A1 (nl) Pyrazine-derivaten.
DE502006001486D1 (de) Motorspindel
DE602006019852D1 (de) Verriegelungsspannfutter
DK1912647T3 (da) Quinolinderivater som antibakterielle midler
NL1032286A1 (nl) Benzoaat zout van 4- (5-methyl-oxazoloó4,5-b!pyridin-2-yl)-1,4-diaza-bicycloó3,2,2!nonaan.
NL1031335A1 (nl) Gesubstitueerde N-sulfonylaminofenylethyl-2-fenoxyaceetamideverbindingen.
DK1912648T3 (da) Quinolinderivater som antibakterielle midler
NL1031627A1 (nl) Acylaminobicyclische heteroaromatische verbindingen en toepassingen daarvan.
DE502006001086D1 (de) Sitz- bzw. Liegemöbel
ATE435865T1 (de) Als pde5-inhibitoren verwendete pyrazoloä4,3- düpyrimidin-5-ylderivate
DK1912649T3 (da) Quinolinderivater som antibakterielle midler
DK1898914T3 (da) Quinolinderivater som antibakterielle midler
NL1030012A1 (nl) Chinolineverbindingen.
ATE489386T1 (de) Naphthyridin-derivate
ITMO20050110A1 (it) Dispositivi di bloccaggio.
NL1031525A1 (nl) 7-Fluor-1,3-dihydroindool-2-onoxazolidinonen als antibacteriele middelen.
FR2905401B1 (fr) Serrure motorisee autonome.
IT1369596B1 (it) Complessi idrossimetilfosfinici di rame e loro impiego come agenti antitumorali.
ES1061035Y (es) Colgador para vasos.
ITRM20050138U1 (it) Cono-gelato di tipo perfezionato.
ITRM20050557A1 (it) Cono-gelato di tipo perfezionato.

Legal Events

Date Code Title Description
AD1A A request for search or an international type search has been filed
RD2N Patents in respect of which a decision has been taken or a report has been made (novelty report)

Effective date: 20070403

PD2B A search report has been drawn up
V1 Lapsed because of non-payment of the annual fee

Effective date: 20100301